BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15729605)

  • 21. Complete remission of brain metastases from ovarian carcinoma with carboplatin.
    Cormio G; Gabriele A; Maneo A; Zanetta G; Bonazzi C; Landoni F
    Eur J Obstet Gynecol Reprod Biol; 1998 May; 78(1):91-3. PubMed ID: 9605456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93).
    Schink JC; Weller E; Harris LS; Cella D; Gerstner J; Falkson C; Wadler S
    Cancer J; 2001; 7(2):155-64. PubMed ID: 11324769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission induction with carboplatin-epirubicin-prednimustine followed by consolidation radiotherapy in advanced ovarian cancer.
    Petru E; Pickel H; Heydarfadai M; Lahousen M
    Int J Clin Pharmacol Res; 1992; 12(4):205-7. PubMed ID: 1297644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral metastases secondary to ovarian cancer: still an unusual event.
    Bruzzone M; Campora E; Chiara S; Giudici S; Merlini L; Simoni C; Mammoliti S; Rubagotti A; Rosso R
    Gynecol Oncol; 1993 Apr; 49(1):37-40. PubMed ID: 8482558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer.
    Minagawa Y; Kigawa J; Kanamori Y; Itamochi H; Terakawa N; Okada M; Kitada F
    Gynecol Oncol; 2006 Jun; 101(3):495-8. PubMed ID: 16375950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of carboplatin based combination chemotherapy on ovarian cancer.
    Feng Y; Zhang X; Sun H
    Chin Med J (Engl); 1996 May; 109(5):349-52. PubMed ID: 9208489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinomatous meningitis associated with ovarian cancer complicated by SIADH.
    Hasegawa T; Nakashima A; Ishimaru M; Shima T; Hidaka T; Saito S
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):739-42. PubMed ID: 20414039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of paclitaxel and cisplatin in a patient with epithelial ovarian cancer and human immunodeficiency virus.
    Knox SN; Robinson JB; Im DD; Logan L; Rosenshein NB
    Gynecol Oncol; 2000 Jan; 76(1):118-22. PubMed ID: 10620453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
    Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
    Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
    Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD
    Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of rapidly growing ovarian squamous cell carcinoma successfully controlled by weekly paclitaxel-carboplatin administration.
    Ohtani K; Sakamoto H; Masaoka N; Shimada K; Kanaeda T; Kurihara M; Nagai N; Satoh K
    Gynecol Oncol; 2000 Dec; 79(3):515-8. PubMed ID: 11104632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination chemotherapy with docetaxel and carboplatin for epithelial ovarian cancer].
    Misawa H; Ochiai K; Yasuda M; Tanaka T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():546-9. PubMed ID: 15535305
    [No Abstract]   [Full Text] [Related]  

  • 36. [A case of ovarian cancer with Parkinson's disease treated by combined chemotherapy with paclitaxel and carboplatin followed by surgery].
    Furukawa M; Fujiwara H; Urabe S; Egawa M; Fujitoh N; Sakashita T; Date K; Mizunoe T; Ueda K; Urabe T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2129-32. PubMed ID: 14712777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
    Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
    Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
    Fortin D; Gendron C; Boudrias M; Garant MP
    Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer.
    Martino MA; Miller E; Grendys EC
    Gynecol Oncol; 2005 May; 97(2):710-2. PubMed ID: 15863189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
    Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA
    Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.